Application of artificial neural networks for the prediction of lymph node metastases to the ipsilateral axilla initial experience in 194 patients using magnetic resonance mammography

Acta Radiologica

Volumn 51, Issue 8, 2010, Pages 851-858

  Dietzel, Matthias ^a   Baltzer, Pascal A T ^a   Dietzel, Andreas ^b   Vag, Tibor ^d   Gröschel, Tobias ^a   Gajda, Mieczyslaw ^c   Camara, Oumar ^a   Kaiser, Werner A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Institute of Pathology   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Breast; Neoplasms; Primary; Prognosis

Indexed keywords

ACTIVATION FUNCTIONS; AREA UNDER THE CURVES; ARTIFICIAL NEURAL NETWORK; BODY WEIGHT; BREAST; BREAST CANCER; BREAST LESION; BREAST MRI; COMPLEX TASK; CONFIDENCE INTERVAL; DATA SETS; DESCRIPTORS; DIAGNOSTIC ACCURACY; GD-DTPA; HYPERBOLIC TANGENT; LYMPH NODE METASTASIS; MULTI LAYER PERCEPTRON; NEOPLASMS; PRIMARY; PROGNOSIS; STUDY DESIGN; TEST SAMPLES; TRAINING AND TESTING; TRAINING SAMPLE;

BODY FLUIDS; FORECASTING; GADOLINIUM; HYPERBOLIC FUNCTIONS; MAGNETIC RESONANCE; PATHOLOGY; TUMORS;

NEURAL NETWORKS;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; AXILLA; BREAST TUMOR; COMPUTER ASSISTED DIAGNOSIS; FEASIBILITY STUDY; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; DIAGNOSIS, COMPUTER-ASSISTED; FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); SENSITIVITY AND SPECIFICITY;

EID: 77956502119     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.3109/02841851.2010.498444     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249
2. Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A, Jordan VC. Early breast cancer. Lancet 2009;373:1463-1479
3. Donegan WL. Tumor-related prognostic factors for breast cancer. CA Cancer J Clin 1997;47:28-51.
4. Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren RM, Dixon JM, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008;26:3248-3258
5. Lee SH, Cho N, Kim SJ, Cha JH, Cho KS, Ko ES, et al. Correlation between high resolution dynamic MR features and prognostic factors in breast cancer. Korean J Radiol 2008;9:10-18.
6. Komatsu S, Lee CJ, Ichikawa D, Hamashima T, Morofuji N, Shirono K, et al. Predictive value of the time-intensity curves on dynamic contrast-enhanced magnetic resonance imaging for lymphatic spreading in breast cancer. Surg Today 2005; 35:720-724
7. Szabo BK, Aspelin P, Kristoffersen Wiberg M, Tot T, Bone B. Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 2003;13:2425-2435
8. Tuncbilek N, Karakas HM, Okten OO. Dynamic magnetic resonance imaging in determining histopathological prognostic factors of invasive breast cancers. Eur J Radiol 2005; 53:199-205.
9. Szabo BK, Aspelin P, Wiberg MK, Bone B. Dynamic MR imaging of the breast. Analysis of kinetic and morphologic diagnostic criteria. Acta Radiol 2003;44:379-386
10. Bone B, Szabo BK, Perbeck LG, Veress B, Aspelin P. Can contrast-enhanced MR imaging predict survival in breast cancer? Acta Radiol 2003;44:373-378
11. Loiselle CR, Eby PR, Demartini WB, Peacock S, Bittner N, Lehman CD, et al. Dynamic contrast-enhanced MRI kinetics of invasive breast cancer: a potential prognostic marker for radiation therapy. Int J Radiat Oncol Biol Phys 2009;76: 1314-1319
12. Bahri S, Chen JH, Yu HJ, Kuzucan A, Nalcioglu O, Su MY. Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer? Ann Oncol 2008;19:822-824
13. Chang YW, Kwon KH, Choi DL, Lee DW, Lee MH, Lee HK, et al. Magnetic resonance imaging of breast cancer and correlation with prognostic factors. Acta Radiol 2009;50: 990-998
14. Hsiang DJ, Yamamoto M, Mehta RS, Su MY, Baick CH, Lane KT, et al. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab. Arch Surg 2007;142:855-861
15. Burke HB, Hoang A, Iglehart JD, Marks JR. Predicting response to adjuvant and radiation therapy in patients with early stage breast carcinoma. Cancer 1998;82:874-877
16. Pena-Reyes CA, Sipper M. A fuzzy-genetic approach to breast cancer diagnosis. Artif Intell Med 1999;17:131-155
17. Seker H, Odetayo MO, Petrovic D, Naguib RN, Bartoli C, Alasio L, et al. Assessment of nodal involvement and survival analysis in breast cancer patients using image cytometric data: statistical, neural network and fuzzy approaches. Anticancer Res 2002;22:433-438
18. Meinel LA, Stolpen AH, Berbaum KS, Fajardo LL, Reinhardt JM. Breast MRI lesion classifi cation: improved performance of human readers with a backpropagation neural network computer-aided diagnosis (CAD) system. J Magn Reson Imaging 2007;25:89-95.
19. Vomweg TW, Teifke A, Kauczor HU, Achenbach T, Rieker O, Schreiber WG, et al. [Self-organizing neural networks for automatic detection and classifi cation of contrast (media) enhancement of lesions in dynamic MR-mammography. ] Rofo 2005;177:703-713 (in German).
20. Szabo BK, Wiberg MK, Bone B, Aspelin P. Application of artifi cial neural networks to the analysis of dynamic MR imaging features of the breast. Eur Radiol 2004;14:1217-1225
21. Dietzel M, Baltzer PA, Vag T, Gröschel T, Gajda M, Camara O, et al. Application of breast MRI for prediction of lymph node metastases - systematic approach using 17 individual descriptors and a dedicated decision tree. Acta Radiol 2010 (in press).
22. Bland M. An introduction to medical statistics. Oxford: Oxford University Press; 2000.
23. Malich A, Fischer DR, Wurdinger S, Boettcher J, Marx C, Facius M, et al. Potential MRI interpretation model: differentiation of benign from malignant breast masses. Am J Roentgenol 2005;185:964-970
24. Kaiser WA. Signs in MR-mammography. Berlin: Springer; 2007.
25. American College of Radiology (ACR). ACR BI-RADS® - MRI. In: Breast imaging reporting and data system atlas (BI-RADS atlas). 4th edition. Reston, VA: American College of Radiology; 2003.
26. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999;213:881-888
27. Fischer DR, Baltzer P, Malich A, Wurdinger S, Freesmeyer MG, Marx C, et al. Is the "blooming sign" a promising additional tool to determine malignancy in MR mammography? Eur Radiol 2004;14:394-401.
28. Dietzel M, Baltzer PA, Vag T, Gajda M, Camara O, Kaiser WA. The hook sign for differential diagnosis of malignant from benign lesions in magnetic resonance mammography: experience in a study of 1084 histologically verifi ed cases. Acta Radiol 2010;51:137-143
29. Dietzel M, Baltzer PA, Vag T, Herzog A, Gajda M, Camara O, et al. The adjacent vessel sign on breast MRI: new data and a subgroup analysis for 1,084 histologically verified cases. Korean J Radiol 2010;11:178-186
30. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term followup. Histopathology 1991;19:403-410
31. Sobin LH, Wittekind C, editors. TNM classifi cation of malignant tumours. New York: Wiley-Liss; 2002.
32. Deurloo EE, Tanis PJ, Gilhuijs KG, Muller SH, Kroger R, Peterse JL, et al. Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer 2003;39:1068-1073
33. Abe H, Schmidt RA, Kulkarni K, Sennett CA, Mueller JS, Newstead GM. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge coreneedle biopsy - clinical experience in 100 patients. Radiology 2009;250:41-49
34. van Rijk MC, Deurloo EE, Nieweg OE, Gilhuijs KG, Peterse JL, Rutgers EJ, et al. Ultrasonography and fi neneedle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy. Ann Surg Oncol 2006;13:31-35
35. Baltzer PA, Dietzel M, Vag T, Beger S, Freiberg C, Herzog AB, et al. Can color-coded parametric maps improve dynamic enhancement pattern analysis in MR mammography? Rofo 2009;182:254-260
36. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988;240:1285-1293
37. Baltzer PAT, Renz DM, Herrmann KH, Dietzel M, Krumbein I, Gajda M, et al. Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques. Eur Radiol 2009;19:1612-1620
38. Mountford C, Ramadan S, Stanwell P, Malycha P. Proton MRS of the breast in the clinical setting. NMR Biomed 2009;22:54-64.
39. Baltzer PAT, Renz DM, Kullnig PE, Gajda M, Camara O, Kaiser WA. Application of computer-aided diagnosis (CAD) in MR-mammography (MRM): do we really need whole lesion time curve distribution analysis? Acad Radiol 2009;16:435-442